MeSH Browser

MeSH Supplementary: atoltivimab, maftivimab, and odesivimab-ebgn drug combination
Unique ID: C000711952
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000711952
Entry Term(s): Inmazeb; R3470-3471-3479; REGN EB3; REGN-3470-3471-3479; REGN-EB3; REGN3470-3471-3479; REGNEB3; atoltivimab, maftivimab, and odesivimab drug combination; atoltivimab, maftivimab, odesivimab
Pharm Action: Antiviral Agents
Registry Numbers: 0
Heading Mapped to: *Drug Combinations; *Antibodies, Monoclonal, Humanized
Frequency: 9
Source: Drugs. 2021 Jan;81(1):175-178.
Date of Entry: 2020/12/23
Revision Date: 2021/03/04

Concept UI: M000744825
Registry Numbers: 0
Terms: REGN-EB3 Preferred Term
Term UI T001101184
Date03/04/2021
LexicalTag LAB
ThesaurusID NLM (2021); REGN-3470-3471-3479
Term UI T001101188
Date03/04/2021
LexicalTag NON
ThesaurusID NLM (2021); REGN3470-3471-3479
Term UI T001101189
Date03/04/2021
LexicalTag LAB
ThesaurusID NLM (2021); REGNEB3
Term UI T001101185
Date03/04/2021
LexicalTag LAB
ThesaurusID NLM (2021); REGN EB3
Term UI T001101186
Date03/04/2021
LexicalTag LAB
ThesaurusID NLM (2021); R3470-3471-3479
Term UI T001101187
Date03/04/2021
LexicalTag LAB
ThesaurusID NLM (2021)

atoltivimab, maftivimab, and odesivimab-ebgn drug combination MeSH Supplementary Concept Data 2025